Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment

Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment

Bibliographic Details
Main Authors: Jialu Lv, Jianqing Lin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Asian Journal of Andrology
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2021;volume=23;issue=3;spage=229;epage=230;aulast=Lv

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2021;volume=23;issue=3;spage=229;epage=230;aulast=Lv

Similar Items